Sacituzumab govitecan in previously treated hormone receptor-positive/HER2-negative metastatic breast cancer: fi nal results from a phase I/II, single-arm, basket trial

Kalinsky, K; Diamond, JR; Vahdat, LT; Tolaney, SM; Juric, D; O'Shaughnessy, J; Moroose, RL; Mayer, IA; Abramson, VG; Goldenberg, DM; Sharkey, RM; Maliakal, P; Hong, Q; Goswami, T; Wegener, WA; Bardia, A

Kalinsky, K (corresponding author), Columbia Univ, Herbert Irving Comprehens Canc Ctr, Irving Med Ctr, 1130 St Nicholas Ave, New York, NY 10032 USA.

ANNALS OF ONCOLOGY, 2020; 31 (12): 1709

Abstract

Background: Trophoblast cell-surface antigen-2 (Trop-2) is expressed in epithelial cancers, including hormone receptor -positive (HR+) metastatic brea......

Full Text Link